AMB-31352-25312
3 vaccinations
1 coded response
30 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2020-12-14
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-14
Registered in v-safe
-
2020-12-14
Dose 1 — Pfizer-BioNTech
- 2020-12-14
- 2020-12-15
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-28
- 2021-01-04
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-06
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-09
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-20
- 2021-01-29
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-09-04
Dose 3 — Moderna
- 2021-09-28
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-12-04
- 2022-03-06
-
2022-09-04
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis — Feeling: FairFree text: ColdMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-14 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-09-04 | Moderna | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release